U of Iowa Settles Dispute with Amgen over Stinski Patents; Abbott Suit Still Ongoing | GenomeWeb

This article was originally published on Aug. 14.

Amgen and the University of Iowa Research Foundation have settled a patent-infringement lawsuit filed last year by UIRF related to a pair of patents for a cytomegalovirus promoter used to manufacture a number of marketed vaccines and therapeutics, Amgen officials said this week.

The Iowa Press-Citizen reported this week that the settlement was reached in March and was for $19 million. However, it also reported that UI officials had yet to comment on the matter.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.